Anzeige
Mehr »
Login
Sonntag, 05.12.2021 Börsentäglich über 12.000 News von 683 internationalen Medien
Unfassbar! New Yorker Investmentbank der ersten Reihe ruft 25-USD-Kursziel aus! +735%
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
05.11.Pfizer's COVID-19 pill cuts hospitalisation/death risk by 89%
05.11.Novartis' iptacopan hits endpoints in mid-stage study
05.11.NICE issues draft recommendation for new kidney disease treatment
04.11.Researchers find HPV vaccine cuts cervical cancer by 87%
04.11.UK approval for MSD/Ridgeback's COVID-19 antiviral med
04.11.Guardant Health and Royal Marsden NHS Foundation Trust announce partnership
04.11.NICE recommends Namuscla for NHS to treat genetic disorder
03.11.Novartis signs $1.3bn deal with UK-based Dunad
03.11.ICEBERG study demonstrates improved outcomes of nasal spray for TRD
03.11.EMA ends rolling review for COVID antibodies
02.11.First authorisation for Novavax COVID-19 jab announced
02.11.Global vaccine trade surpasses $42 billion
02.11.Study reveals lack of diagnostic accuracy in online consultations
01.11.AZ to transfer certain drug rights to Covis Pharma for $270m
01.11.UK government to cut cost of repeatable HRT prescriptions
01.11.Walk-in centres for COVID booster jabs open across England
29.10.Gilead and MSD collab on Trodelvy/Keytruda breast cancer trial
29.10.Takeda snaps up GammaDelta Therapeutics
29.10.Novartis UK awarded Innovation Passport for investigational therapy
29.10.Clinical Researcher of the Year - The Americas 2021 winners announced
28.10.EMA nod for excessive daytime sleepiness med Ozawade
28.10.FDA panel OK's Pfizer/BioNTech jab for children aged five to 11
28.10.Record 1.6 million receive COVID-19 boosters over seven days
28.10.Strategic collaboration strengthens lupus clinical research in UK
27.10.New collaboration to develop next-gen diagnostic platform for early cancer detection